NOVANTA INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 159 USD | -0.25% |
|
+2.34% | -6.12% |
| Apr. 02 | Novanta Insider Sold Shares Worth $860,010, According to a Recent SEC Filing | MT |
| Mar. 01 | Novanta Insider Sold Shares Worth $511,200, According to a Recent SEC Filing | MT |
Financials (USD)
| Sales 2024 * | 986M | Sales 2025 * | 1.09B | Capitalization | 5.72B |
|---|---|---|---|---|---|
| Net income 2024 * | 80M | Net income 2025 * | 109M | EV / Sales 2024 * | 5.93 x |
| Net Debt 2024 * | 130M | Net Debt 2025 * | 9M | EV / Sales 2025 * | 5.28 x |
| P/E ratio 2024 * |
71.2
x | P/E ratio 2025 * |
52.4
x | Employees | 2,900 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.14% |
More Fundamentals
* Assessed data
More news
Latest transcript on Novanta Inc.
More recommendations
More press releases
| 1 day | +4.10% | ||
| 1 week | +0.38% | ||
| Current month | -8.81% | ||
| 1 month | -7.91% | ||
| 3 months | -1.29% | ||
| 6 months | +16.34% | ||
| Current year | -5.36% |
1 week
146.86
160.52
1 month
146.86176.22
Current year
146.86181.89
1 year
111.20187.61
3 years
110.84187.61
5 years
66.44187.61
10 years
11.08187.61
| Managers | Title | Age | Since |
|---|---|---|---|
Matthijs Glastra
CEO | Chief Executive Officer | 55 | 12-10-14 |
Robert Buckley
DFI | Director of Finance/CFO | 49 | 11-01-31 |
Sarah Betadam
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Stephen Bershad
BRD | Director/Board Member | 82 | 10-07-22 |
Lonny Carpenter
BRD | Director/Board Member | 62 | 18-05-09 |
Thomas Secor
BRD | Director/Board Member | 53 | 12-06-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.41% | 152 M€ | -0.54% | - | |
| 0.22% | 509 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 158.1 | -0.80% | 1 412 |
| 24-04-23 | 159.4 | +4.10% | 165,577 |
| 24-04-22 | 153.1 | +2.48% | 145,543 |
| 24-04-19 | 149.4 | -0.41% | 161,045 |
| 24-04-18 | 150 | -2.90% | 190,181 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotes
Novanta Inc. is a supplier of core technology solutions, which give medical and advanced industrial original equipment manufacturers. The Company has three segments. Precision Medicine and Manufacturing segment designs, manufactures and markets photonics-based solutions, including laser scanning, laser beam delivery, carbon dioxide laser, solid state laser, ultrafast laser, and optical light engine products to customers worldwide. Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators, pumps and related disposables; visualization solutions; wireless technologies, video recorders and video integration technologies, and others. Robotics and Automation segment designs, manufactures and markets optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide.
Sector
Electronic Equipment & Parts
Calendar
2024-05-07
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
159.4
USD
Average target price
175.1
USD
Spread / Average Target
+9.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.36% | 5.72B | |
| +15.30% | 68.54B | |
| +37.80% | 61.27B | |
| -4.79% | 33.55B | |
| -19.91% | 27.33B | |
| -5.11% | 14.58B | |
| -13.85% | 9.83B | |
| +3.03% | 9.27B | |
| +73.21% | 8.64B | |
| +20.32% | 7.95B |
- Stock Market
- Equities
- NOVT Stock
